Group B(n=3)-age <3 y r s . , with c h a r a c t e r i s t i c n e u r o l o g i c s i g n s ; Group C(n=9)-a g e s 5-17 y r s . , w i t h neurologic s i g n s . E r e p l e t i o n was achieved by o r a l (n=4; 60 t o 90 IU/kg/day) o r i n t r a m u s c u l a r (n=10;1.0-1.5 IU/kg/day) dl-a-tocopherol.
.
Neurologic s c o r e ( # P t s . ) ---Duration of E ~e p l e t i o n Group B a s e l i n e 6-12 mo. 12-24 mo. 24-36 mo.
A 0 (2) 0 (2) 0
(1) --C 15.6 (9) 12.8 (6) 12.8 (9) 8.3 (6) Conclusion: Vitamin E r e p l e t i o n r e v e r s e s o r p r e v e n t s n e u r o l o g i c a b n o r m a l i t i e s when begun p r i o r t o age 3 y e a r s , whereas o n l y part i a l improvement o c c u r s when t h e r a p y i s begun a f t e r age 5 y e a r s . We recommend s u r v e i l l a n c e f o r and t r e a t m e n t of E d e f i c i e n c y p r i o r t o age 3 y e a r s i n c h i l d r e n w i t h c h r o n i c c h o l e s t a s i s .
TRANSIENT HYPERPHOSPHATASEMIA OF INFANCY. Robert N.
w. Bruce B. G r i l l , John W. Mace, (Spon. by James 703 J . Ouill i a a n ) : Loma Linda Universitv School of Medic i n e , Loma ~i n d $ univGrs;ty Medical Center, ~e p a r t m e n t o f Pedia t r i c s , Loma Linda, CA.
To e v a l u a t e the c l i n i c a l c h a r a c t e r i s t i c s of t r a n s i e n t hyperphosphatasemia o f infancy (THI), a syndrome of marked benign t r a n s i e n t i n c r e a s e of serum a1 kal i n e phosphatase (SAP), we r e t r os p e c t i v e l y s t u d i e d e i g h t p a t i e n t s with t h e following: 1 ) SAP > 3x upper l i m i t s of normal, 2) no hepatobil i a r y , metabolic, neop l a s t i c , o r osseous abnormality, 3) SAP l e v e l r e t u r n i n g t o normal without therapy. Mean age was 9.5 months, range 3-14 months; f i v e p a t i e n t s were female. Mean maximum SAP was 2,460 IU/dl, range 1115-7276 IU/dl ; mean time f o r SAP t o normalize was 4.6 weeks (range 1 . 5 -8 weeks); s i x p a t i e n t s (63%) had g a s t r o i n t e st i n a l symptoms (gastroesophageal r e f l u x , food a l l e r g y , c h r o n i c d i a r r h e a ) . One p a t i e n t was < 5 t h p e r c e n t i l e f o r weight. Serum calcium, phosphorus, transaminases, and b i l i r u b i n were normal. S k e l e t a l radiographs and bone scans were normal. We conclude: 1 ) in i n f a n t s , extreme e l e v a t i o n s of SAP a r e o f t e n benign; 2) a minimal workup should include s k e l e t a l radiographs and l i v e r f u n c t i o n s t u d i e s ; 3) SAP should be repeated biweekly, and i f d e c r e a s i n g e x t e n s i v e s t u d i e s should not be performed. Because o f high incidence o f g a s t r o i n t e s t i n a l (GI) symptoms we s p e c u l a t e t h a t THI may be secondary t o an a c u t e GI i n j u r y with t r a n smucosal passage o f 1 i b e r a t e d i n t e s t i n a l a1 kal i n e phosphatase.
CHANGES IN BODY COMPOSITION IN GROWING LOW BIRTH
WEIGHT INFANTS D.W. S ad , D. S c h i f f , G. Chan.
U n i v e r s i t y o f A1 berta; ~Z p a r t m e n t o f P e d i a t r i c s ,
Edmonton, Canada.
Body composition (BC) was estimated i n 19 premature i n f a n t s by measuring t o t a l body water (TBW) and e x t r a c e l l u l a r f l u i d (ECF) usina a n t i o v r i n e and bromide. In 16 i n f a n t s . measurements o f n i t r o s e ; ( N ) balance were a l s o made weekly. n he d i e t was mother's milk (EBM), 8 c a s e s , formula ( F ) , 2 c a s e s , and mixed EBM and F, 6 c a s e s . In 1 3 c a s e s , i n i t i a l water measurements were made a t a mean age o f 19 days (weight (WT) 1226 +/-2549) and f i n a l l y a t a mean age o f 52 days (WT 2023 +/-2389). In 6 c a s e s o n l y one measurement was made.
This was good c o r r e l a t i o n o f weight with TBW (r=0.97) and ECF (r=0.94) with a n a l y s i s y i e l d i n g t h e equation TBW=43.73+ 0.742WT. There was a t r e n d t o more water r e t e n t i o n with F feeding but small sample s i z e precluded a n a l y s i s . The mean p r o t e i n (P) a c c r e t i o n was 11.82 + I -3.17%. In c a s e s with 2 water measurements, f a t r e t e n t i o n was estimated a s follows:
Fat-Dryweight-P r e t a i n e d . Mean f a t r e t e n t i o n was 11.41% +/-9.4%. In t h e s e 'complete' c a s e s t h e r e was a mean W T g a i n o f 8749, of which 86.8% (6719) was water, 11.41% (1009) was f a t , and 11.7% (1039) was P.
These e s t i m a t e s of n u t r i e n t r e t e n t i o n a r e l e s s than those made by o t h e r s but a r e d e r i v e d by more d i r e c t methods. This r e s e a r c h underscores t h e need t o perform d i r e c t BC measurements i n growth s t u d i e s . Although the activk transport of BS acros; t h e term'inal'ileum has been well documented, analysis of previous studies shows t h a t ileal active transport cannot account f o r total BS recovery (Am J Physiol 244:G507,1983).
To evaluate passive BS absorption in t h e proximal small intestine, weanling male Sprague-Dawley r a t s (age 39 2 4 days; w t 146 + 26 g -mean + SD)
were anesthetized, the common bile duct was cannulated and t h e jejunum (J) and ileum (I) were catheterized and isolated. I ml of taurocholate (TC) solution in concentrations ranging from 0.5 mM t o 10 mM and containing 3~-T C and 1 4~-~o l~e t h~l e n e glycol (PEG -non-absorbable marker) were injected into t h e J. Bile was collected for 90 min. post-injection and counted. J and I were then ligated (to prevent mixing), divided into 8 segments, homogenized and counted. TC absorption from t h e intestine was determined using I~C -P E G a s a reference substance. In all animals, >94% of t h e I~c-PEG marker was found in proximal 3 (segments 1-3).
A linear correlation was found between t h e conc. of T C administered and t h e amount of TC recovered in bile (N=20, r=.91, p < .001). 8.4 + 2.9 % of t h e dose was excreted in bile in 90 minutes. The r a t e of TC absorption was linearly related t o TC conc. (N=13, rz.97, p< .001) and was non-saturable. These findings demonstrate t h a t TC is avidly absorbed by a passive process at physiologic concentrations (8-10 mM) in the proximal small bowel of t h e rat. When calculated for the entire small bowel, passive absorption accounts for between 54 and 69% of total BS secretion and is t h e major mechanism of BS conservation. These findings suggest t h a t rapid proximal BS absorption rather than fecal BS loss is the mechanism f o r decreased intraluminal BS concentration in the neonate. To i n v e s t i g a t e p o s t n a t a l m a t u r a t i o n a l changes of g u t b a r r i e r f u n c t i o n , we used two small i n t e s t i n a l i n v i t r o models. Microv i l l u s membrane (MVM) p r e p a r a t i o n s were used f o r studying membrane s u r f a c e binding and t h e e v e r t e d g u t s a c t y & n i q u e was used f o r studying mucous c o a t binding and uptake of I -l a b ed bovine serum albumin ( 1 2 5~-~~~) and b e t a l a c t o g l o b u l i n (f'31-BLG) i n newborn, preweanling and a d u l t rats. Surface binding of BSA and BLG t o MVM was g r e a t e r from newborn and preweanling r a t s , compared t o a d u l t s (BSA, newborns: 2.74?0.53%; a d u l t s 1.08+0.17%, p<0.001). Binding however was weak and n o n s p e c i f i c . Contrary t o s u r f a c e binding, mucous c o a t binding of BSA and BLG t o preweanl i n g gut s a c s was l e s s than t o adulf2qnes, a s was uptake (BSA binding: 0.94t0.30 v s 3.06t0.74 pg I -p r o t e i n e q u i v a l e n t s /mg mucosal p r o t e i n , p<0.001; BSA uptake: 0.35i0.17 v s 0.71+0.20, p<0.01). Gut s a c binding and uptake were c l o s e l y c o r r e l a t e d i n a d u l t and preweanling animals (r=0.76, p<0.001 f o r BSA; r=0.85, p<0.001 f o r BLG i n preweanlings). These s t u d i e s suggest t h a t immature animals a r e binding more cow's milk p r o t e i n s t o t h e i r MVM, b u t t h a t l e s s p r o t e i n i s bound t o t h e mucous c o a t and taken up by immature gut s a c s . D i f f e r e n t i a l h a n d l i n g , mucous c o a t and MVM binding of food p r o t e i n s i n immature animals may be cont r o l l e d by mucus l a y e r f a c t o r s which a c t t o p r o t e c t t h e underl y i n g MVM.
